The Medical Center has been re-verified as a level I trauma center and a level I pediatric trauma center. UC Davis is one of only three hospitals in the state with level I verification for both adult and pediatric trauma.
UC Davis Health has published one of the earliest studies assessing the use of tecovirimat to treat monkeypox symptoms and skin lesions. The antiviral drug approved for smallpox treatment appeared to be safe and effective in 25 patients with monkeypox.
Camp MIND, a summer day camp for children with neurodevelopmental disabilities like autism and fragile X syndrome was a major success this summer. The program at the UC Davis MIND Institute offered three sessions of crafts, games, music and special guests.
About 50% of all mothers of children with autism spectrum disorder (ASD) had elevated levels of depressive symptoms over 18 months, while rates were much lower (6% to 13.6%) for mothers with neurotypical children in the same period, UCSF researchers report in a new study.
A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone Institutes and UC San Francisco (UCSF), lets scientists introduce especially long DNA sequences to precise locations in the genomes of cells at remarkably high…
Health Media Contacts
Find the best contact for health-related media inquiries.
